HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Long-term outcomes after multidisciplinary management of T3 laryngeal squamous cell carcinomas: Improved functional outcomes and survival with modern therapeutic approaches.

AbstractBACKGROUND:
The purpose of this study was to evaluate the long-term outcomes after initial definitive or adjuvant radiotherapy (RT) for T3 laryngeal cancers.
METHODS:
We reviewed 412 patients treated for T3 laryngeal squamous cell cancer from 1985 to 2011.
RESULTS:
The 10-year overall survival (OS) was 35%; disease-specific-survival (DSS) was 61%; locoregional control was 76%; and freedom from distant metastasis was 83%. Chemotherapy, age, performance status <2, node-negative status, and glottic subsite were associated with improved survival (all p < .03). Larynx preservation with induction and/or concurrent chemoradiotherapy (LP-CRT) had better laryngectomy-free survival than RT alone (LP-RT; hazard ratio [HR] = 0.62; 95% confidence interval [CI] = 0.47-0.81; p = .0005); 10-year laryngectomy-free survival rates of the LP-CRT cohort (37%) were higher than those of the LP-RT cohort (18%). The 5-year DSS and OS rates of the LP-CRT cohort (79% and 67%) were better after total laryngectomy with postoperative RT (TL-PORT; 61% and 50%) and LP-RT (64% and 46%; p < .006 for all).
CONCLUSION:
In patients with T3 laryngeal cancers, LP-CRT provides better functional, oncologic, and survival outcomes than historical TL-PORT or LP-RT does. © 2016 Wiley Periodicals, Inc. Head Neck 38: 1739-1751, 2016.
AuthorsClifton D Fuller, Abdallah S R Mohamed, Adam S Garden, G Brandon Gunn, Collin F Mulcahy, Mark Zafereo, Jack Phan, Stephen Y Lai, Jan S Lewin, Katherine A Hutcheson, Steven J Frank, Beth M Beadle, William H Morrison, Adel K El-Naggar, Esengul Kocak-Uzel, Lawrence E Ginsberg, Merril S Kies, Randal S Weber, David I Rosenthal
JournalHead & neck (Head Neck) Vol. 38 Issue 12 Pg. 1739-1751 (12 2016) ISSN: 1097-0347 [Electronic] United States
PMID27466789 (Publication Type: Journal Article)
Copyright© 2016 Wiley Periodicals, Inc.
Topics
  • Adult
  • Aged
  • Analysis of Variance
  • Cancer Care Facilities
  • Carcinoma, Squamous Cell (mortality, pathology, therapy)
  • Chemotherapy, Adjuvant
  • Cohort Studies
  • Disease-Free Survival
  • Female
  • Follow-Up Studies
  • Head and Neck Neoplasms (mortality, pathology, therapy)
  • Humans
  • Kaplan-Meier Estimate
  • Laryngeal Neoplasms (mortality, pathology, therapy)
  • Laryngectomy (methods)
  • Male
  • Middle Aged
  • Multivariate Analysis
  • Neoadjuvant Therapy
  • Neoplasm Invasiveness (pathology)
  • Neoplasm Staging
  • Proportional Hazards Models
  • Radiotherapy, Adjuvant
  • Retrospective Studies
  • Squamous Cell Carcinoma of Head and Neck
  • Survival Analysis
  • Texas
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: